Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 3,086

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*

Desvergne, Béatrice, Wahli, Walter·1999·Endocrine Reviews
DOI 10.1210/edrv.20.5.0380
Open this paper in CoChat — free account

Abstract

I. Introduction II. Molecular Aspects A. PPAR isotypes: identity, genomic organization and chromosomal localization B. DNA binding properties C. PPAR ligand-binding properties D. Alternative pathways for PPAR activation E. PPAR-mediated transactivation properties III. Physiological Aspects A. Differential expression of PPAR mRNAs B. PPAR target genes and functions in fatty acid metabolism C. PPARs and control of inflammatory responses D. PPARs and atherosclerosis E. PPARs and the development of the fetal epidermal permeability barrier F. PPARs, carcinogenesis, and control of the cell cycle IV. Conclusions

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv.20.5.0380

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 383

  1. Brown, 1997, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor., Cell, 89, 331, 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
  2. 1999, A unified nomenclature system for the nuclear receptor superfamily., Cell, 97, 161, 10.1016/S0092-8674(00)80726-6 · DOI · Paper page
  3. Peet, 1998, The LXRs: a new class of oxysterol receptors., Curr Opin Genet Dev, 8, 571, 10.1016/S0959-437X(98)80013-0 · DOI · Paper page
  4. Xing, 1995, Rat PPARδ contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei., Biochem Biophys Res Commun, 217, 1015, 10.1006/bbrc.1995.2871 · DOI
  5. Chen, 1993, Identification of two mPPAR related receptors and evidence for the existence of five subfamily members., Biochem Biophys Res Commun, 196, 671, 10.1006/bbrc.1993.2302 · DOI
  6. Zhu, 1993, Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver., J Biol Chem, 268, 26817, 10.1016/S0021-9258(19)74184-2 · DOI · Paper page
  7. Kliewer, 1994, Differential expression and activation of family murine peroxisome proliferator-activated receptors., Proc Natl Acad Sci USA, 91, 7355, 10.1073/pnas.91.15.7355 · DOI · Paper page
  8. Amri, 1995, Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator- activated receptors., J Biol Chem, 270, 2367, 10.1074/jbc.270.5.2367 · DOI · Paper page
  9. Göttlicher, 1992, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor., Proc Natl Acad Sci USA, 89, 4653, 10.1073/pnas.89.10.4653 · DOI · Paper page
  10. Aperlo, 1995, cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPARγ., Gene, 162, 297, 10.1016/0378-1119(95)00196-D · DOI
  11. Schmidt, 1992, Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids., Mol Endocrinol, 6, 1634
  12. Sher, 1993, cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor., Biochemistry, 32, 5598, 10.1021/bi00072a015 · DOI · Paper page
  13. Greene, 1995, Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping., Gene Expr, 4, 281
  14. Dreyer, 1992, Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors., Cell, 68, 879, 10.1016/0092-8674(92)90031-7 · DOI · Paper page
  15. Laudet, 1992, Evolution of the nuclear receptor gene superfamily., EMBO J, 11, 1003, 10.1002/j.1460-2075.1992.tb05139.x · DOI · Paper page
  16. Knoll, 1992, The early evolution of eukaryotes - A geological perspective., Science, 256, 622, 10.1126/science.1585174 · DOI · Paper page
  17. Keese, 1992, Origins of genes - Big bang or continuous creation., Proc Natl Acad Sci USA, 89, 9489, 10.1073/pnas.89.20.9489 · DOI · Paper page
  18. Beamer, 1997, Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-γ (hPPARγ) gene., Biochem Biophys Res Commun, 233, 756, 10.1006/bbrc.1997.6540 · DOI
  19. Yoshikawa, 1996, Assignment of the human nuclear hormone receptor, NUC1 (PPARδ), to chromosome 6p21.1-p21.2., Genomics, 35, 637, 10.1006/geno.1996.0417 · DOI
  20. Jones, 1995, Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome proliferator-activated receptor genes., Eur J Biochem, 233, 219, 10.1111/j.1432-1033.1995.219_1.x · DOI
  21. Gearing, 1994, Structure of the mouse peroxisome proliferator activated receptor α gene., Biochem Biophys Res Commun, 199, 255, 10.1006/bbrc.1994.1222 · DOI
  22. Krey, 1993, Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid × receptor and activation by fatty acids., J Steroid Biochem Mol Biol, 47, 65, 10.1016/0960-0760(93)90058-5 · DOI
  23. Zhu, 1995, Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms., Proc Natl Acad Sci USA, 92, 7921, 10.1073/pnas.92.17.7921 · DOI · Paper page
  24. Fajas, 1997, The organization, promoter analysis, and expression of the human PPAR-γ gene., J Biol Chem, 272, 18779, 10.1074/jbc.272.30.18779 · DOI · Paper page
  25. Fajas, 1998, PPARgamma3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter., FEBS Lett, 438, 55, 10.1016/S0014-5793(98)01273-3 · DOI · Paper page
  26. Glass, 1994, Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers., Endocr Rev, 15, 391
  27. Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors., Nature, 358, 771, 10.1038/358771a0 · DOI · Paper page
  28. Palmer, 1995, Novel sequence determinants in peroxisome proliferator signaling., J Biol Chem, 270, 16114, 10.1074/jbc.270.27.16114 · DOI · Paper page
  29. IJpenberg, 1997, Polarity and specific sequence requirements of PPAR-RXR heterodimer binding to DNA: a functional analysis of the malic enzyme gene PPRE., J Biol Chem, 272, 20108, 10.1074/jbc.272.32.20108 · DOI · Paper page
  30. Juge-Aubry, 1997, DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: importance of the 5′ flanking region., J Biol Chem, 272, 25252, 10.1074/jbc.272.40.25252 · DOI · Paper page
  31. Osada, 1997, Identification of an extended half-site motif required for the function of peroxisome proliferator-activated receptor alpha., Genes to Cells, 2, 315, 10.1046/j.1365-2443.1997.1220319.x · DOI
  32. DiRenzo, 1997, Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid × receptor heterodimers with ligands, coactivators, and corepressors., Mol Cell Biol, 17, 2166, 10.1128/MCB.17.4.2166 · DOI · Paper page
  33. Mangelsdorf, 1995, The RXR heterodimers and orphan receptors., Cell, 83, 841, 10.1016/0092-8674(95)90200-7 · DOI · Paper page
  34. Hsu, 1998, A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding., J Biol Chem, 273, 27988, 10.1074/jbc.273.43.27988 · DOI
  35. Perlmann, 1993, Determinants for selective RAR and TR recognition of direct repeat HREs., Genes Dev, 7, 1411, 10.1101/gad.7.7b.1411 · DOI · Paper page
  36. Kurokawa, 1993, Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers., Genes Dev, 7, 1423, 10.1101/gad.7.7b.1423 · DOI · Paper page
  37. Mader, 1993, The patterns of binding of RAR, RXR and TR homodimers and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains., EMBO J, 12, 5029, 10.1002/j.1460-2075.1993.tb06196.x · DOI · Paper page
  38. Lee, 1993, Structure of the retinoid × receptor α DNA binding domain: a helix required for homodimeric DNA binding., Science, 260, 1117, 10.1126/science.8388124 · DOI · Paper page
  39. Towers, 1993, DNA target selectivity by the vitamin-D3 receptor: mechanism of dimer binding to an asymmetric repeat element., Proc Natl Acad Sci USA, 90, 6310, 10.1073/pnas.90.13.6310 · DOI
  40. Predki, 1994, Ordered binding of retinoic acid and retinoid × receptors to asymmetric response elements involves determinants adjacent to the DNA-binding domain., Mol Endocrinol, 8, 31
  41. Zechel, 1994, The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats., EMBO J, 13, 1425, 10.1002/j.1460-2075.1994.tb06396.x · DOI · Paper page
  42. Zechel, 1994, Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements., EMBO J, 13, 1414, 10.1002/j.1460-2075.1994.tb06395.x · DOI · Paper page
  43. Rastinejad, 1995, Structural determinants of nuclear receptor assembly on DNA direct repeats., Nature, 375, 203, 10.1038/375203a0 · DOI · Paper page
  44. Zhao, 1998, Structural elements of an orphan nuclear receptor-DNA complex., Mol Cell, 1, 849, 10.1016/S1097-2765(00)80084-2 · DOI
  45. Gervois, 1999, Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element., Mol Endocrinol, 13, 400
  46. Nakshatri, 1994, The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4 and ARP-1 homo- and heterodimers., J Biol Chem, 269, 890, 10.1016/S0021-9258(17)42196-X · DOI
  47. Fraser, 1998, DNA binding and transcription activation specificity of hepatocyte nuclear factor 4., Nucleic Acids Res, 26, 2702, 10.1093/nar/26.11.2702 · DOI
  48. Baes, 1995, Antagonism of COUP-TF and PPARα/RXRα on the activation of the malic enzyme gene promoter - modulation by 9-cis RA., Biochem Biophys Res Commun, 215, 338, 10.1006/bbrc.1995.2471 · doi:10.1006/bbrc.1995.2471
  49. Miyata, 1993, Chicken ovalbumin upstream promoter transcription factor (COUP - TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signalling., J Biol Chem, 268, 19169, 10.1016/S0021-9258(19)36491-9 · DOI
  50. Winrow, 1994, Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4., Gene Expr, 4, 53
  51. Hertz, 1996, Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators., J Biol Chem, 271, 218, 10.1074/jbc.271.1.218 · DOI
  52. Nakhastri, 1998, Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR, RXR through common response elements., Nucleic Acids Res, 26, 2491, 10.1093/nar/26.10.2491 · DOI
  53. Keller, 1995, Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements., Mol Endocrinol, 9, 794
  54. Nunez, 1997, Retinoid × receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor., Mol Cell Endocrinol, 127, 27, 10.1016/S0303-7207(96)03980-9 · DOI
  55. Chu, 1995, Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of gene encoding β-oxidation enzymes: cross-talk between peroxisome proliferator and T3 signaling pathways., Proc Natl Acad Sci USA, 92, 11593, 10.1073/pnas.92.25.11593 · DOI
  56. Juge-Aubry, 1995, Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor: possible role of a leucine zipper-like heptad repeat., J Biol Chem, 270, 18117, 10.1074/jbc.270.30.18117 · DOI
  57. Jow, 1995, The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPARα and thyroid hormone receptors., J Biol Chem, 270, 3836, 10.1074/jbc.270.8.3836 · DOI
  58. Tolon, 1998, Activation of the prolactin gene by peroxisome-proliferator activated receptor-α appears to be DNA binding-independent., J Biol Chem, 273, 26652, 10.1074/jbc.273.41.26652 · DOI
  59. Keller, 1993, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers., Proc Natl Acad Sci USA, 90, 2160, 10.1073/pnas.90.6.2160 · DOI · Paper page
  60. Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)., J Biol Chem, 270, 12953, 10.1074/jbc.270.22.12953 · DOI · Paper page
  61. Kliewer, 1995, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation., Cell, 83, 813, 10.1016/0092-8674(95)90194-9 · DOI · Paper page
  62. Forman, 1995, 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ., Cell, 83, 803, 10.1016/0092-8674(95)90193-0 · DOI · Paper page
  63. Keller, 1997, PPARα structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents., Biol Chem, 378, 651, 10.1515/bchm.1997.378.7.651 · DOI
  64. Kersten, 1999, Adopting orphans: finding ligands, In: Picard D (ed) Nuclear Receptor: A Practical Approach. Oxford University Press, Oxford, UK, pp, 71
  65. Bosworth, 1989, Scintillation proximity assay., Nature, 341, 167, 10.1038/341167a0 · DOI · Paper page
  66. Nichols, 1998, Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain., Anal Biochem, 257, 112, 10.1006/abio.1997.2557 · DOI
  67. Dowell, 1997, Ligand-induced peroxisome proliferator-activated receptor α conformational change., J Biol Chem, 272, 2013, 10.1074/jbc.272.3.2013 · DOI
  68. Krey, 1997, Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by CARLA., Mol Endocrinol, 11, 779, 10.1210/mend.11.6.0007 · DOI · Paper page
  69. Berger, 1999, Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects., J Biol Chem, 274, 6718, 10.1074/jbc.274.10.6718 · DOI · Paper page
  70. Willson, 1997, Peroxisome proliferator-activated receptor (PPAR) agonists., Curr Opin Chem Biol, 1, 235, 10.1016/S1367-5931(97)80015-4 · DOI · Paper page
  71. Johnson, 1997, Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors., J Steroid Biochem Mol Biol, 63, 1, 10.1016/S0960-0760(97)00064-2 · DOI
  72. Ellinghaus, 1999, Phytanic acid activates the peroxisome proliferator-activated receptor α (PPARα) in sterol carrier protein2-/sterol carrier protein x-deficient mice., J Biol Chem, 274, 2766, 10.1074/jbc.274.5.2766 · DOI
  73. Devchand, 1998, Leukotriene B4: agonist for the fat regulator PPARα, In: Rodger I, Botting J, Dahlén S-E (eds) Leukotrienes: New Concepts and Targets for Therapy. Kluwer Academic Publishers and William Harvey Press, pp, 119
  74. Devchand, J Biol Chem, 274, 23341, 10.1074/jbc.274.33.23341 · DOI
  75. Brock, 1995, Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages., J Biol Chem, 270, 21652, 10.1074/jbc.270.37.21652 · DOI
  76. Chen, 1998, Determinants of 5-lipoxygenase nuclear localisation using green fluorescent protein/5-lipoxygenase fusion proteins., J Biol Chem, 273, 31237, 10.1074/jbc.273.47.31237 · DOI
  77. Palmer, 1998, cis-Parinaric acid is a ligand for the human peroxisome proliferator activated receptor γ: development of a novel spectrophotometric assay for the discovery of PPARγ ligands., FEBS Lett, 431, 476, 10.1016/S0014-5793(98)00818-7 · DOI
  78. Berger, 1996, Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice., Endocrinology, 137, 4189, 10.1210/endo.137.10.8828476 · DOI · Paper page
  79. Henke, 1998, N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents., J Med Chem, 41, 5020, 10.1021/jm9804127 · DOI · Paper page
  80. Brown, 1997, Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library., Chem Biol, 4, 909, 10.1016/S1074-5521(97)90299-4 · DOI
  81. Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXRα., Nature, 375, 377, 10.1038/375377a0 · DOI · Paper page
  82. Renaud, 1995, Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid., Nature, 378, 681, 10.1038/378681a0 · DOI · Paper page
  83. Wagner, 1995, A structural role for hormone in the thyroid hormone receptor., Nature, 378, 690, 10.1038/378690a0 · DOI · Paper page
  84. Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ., Nature, 395, 137, 10.1038/25931 · DOI · Paper page
  85. Uppenberg, 1998, Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ., J Biol Chem, 273, 31108, 10.1074/jbc.273.47.31108 · DOI · Paper page
  86. Hsu, 1995, A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators., Mol Pharmacol, 48, 559, 10.1016/S0026-895X(25)10506-3 · DOI
  87. Shalev, 1996, The peroxisome proliferator-activated receptor α is a phosphoprotein: regulation by insulin., Endocrinology, 137, 4499, 10.1210/endo.137.10.8828512 · DOI
  88. Juge-Aubry, 1999, Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans- activating domain., J Biol Chem, 274, 10505, 10.1074/jbc.274.15.10505 · DOI · Paper page
  89. Zhang, 1996, Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ., J Biol Chem, 271, 31771, 10.1074/jbc.271.50.31771 · DOI · Paper page
  90. Camp, 1997, Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase., J Biol Chem, 272, 10811, 10.1074/jbc.272.16.10811 · DOI · Paper page
  91. Hu, 1996, Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ., Science, 274, 2100, 10.1126/science.274.5295.2100 · DOI · Paper page
  92. Camp, 1999, c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity., Endocrinology, 140, 392, 10.1210/endo.140.1.6457 · DOI · Paper page
  93. Reginato, 1998, Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ., J Biol Chem, 273, 1855, 10.1074/jbc.273.4.1855 · DOI · Paper page
  94. Shao, 1998, Interdomain communication regulating ligand binding by PPAR-γ., Nature, 396, 377, 10.1038/24634 · DOI · Paper page
  95. Gabbay, 1996, Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway., J Biol Chem, 271, 1890, 10.1074/jbc.271.4.1890 · DOI
  96. Zhou, 1999, Cross-talk between Janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-α (PPARα) signaling pathways., J Biol Chem, 274, 2672, 10.1074/jbc.274.5.2672 · DOI
  97. Gearing, 1993, Interaction of the peroxisome-proliferator-activated receptor and retinoid X-receptor., Proc Natl Acad Sci USA, 90, 1440, 10.1073/pnas.90.4.1440 · DOI · Paper page
  98. Vu-Dac, 1996, Retinoids increase human apolipoprotein A-II expression through activation of the retinoid X receptor but not the retinoic acid receptor., Mol Cell Biol, 16, 3350, 10.1128/MCB.16.7.3350 · DOI
  99. Poirier, 1997, 9-cis-retinoic acid enhances fatty acid-induced expression of the liver fatty acid-binding protein gene., FEBS Lett, 412, 480, 10.1016/S0014-5793(97)00830-2 · DOI
  100. Mukherjee, 1997, Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists., Nature, 386, 407, 10.1038/386407a0 · DOI · Paper page
  101. Mukherjee, 1998, RXR agonists activate PPARα-inducible genes, lower triglycerides, and raise HDL levels in vivo., Arterioscler Thromb Vasc Biol, 18, 272, 10.1161/01.ATV.18.2.272 · DOI
  102. Mertz, 1997, Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. A possible role in 9-cis-retinoic acid formation., J Biol Chem, 272, 11744, 10.1074/jbc.272.18.11744 · DOI
  103. Romert, 1998, The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid., Proc Natl Acad Sci USA, 95, 4404, 10.1073/pnas.95.8.4404 · DOI
  104. Forman, 1995, Unique response pathways are established by allosteric interactions among nuclear hormone receptors., Cell, 81, 541, 10.1016/0092-8674(95)90075-6 · DOI · Paper page
  105. Perlmann, 1995, A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1., Genes Dev, 9, 769, 10.1101/gad.9.7.769 · DOI · Paper page
  106. Willy, 1995, LXR, a nuclear receptor that defines a distinct retinoid response pathway., Genes Dev, 9, 1033, 10.1101/gad.9.9.1033 · DOI · Paper page
  107. Kersten, 1995, Retinoid × receptor α forms tetramers in solution., Proc Natl Acad Sci USA, 92, 8645, 10.1073/pnas.92.19.8645 · DOI
  108. Dong, 1998, Heterodimer formation by retinoid × receptor: regulation by ligands and by the receptor’s self-association properties., Biochemistry, 37, 10691, 10.1021/bi980561r · DOI
  109. Mangelsdorf, 1991, A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR., Cell, 66, 555, 10.1016/0092-8674(81)90018-0 · DOI · Paper page
  110. Peters, 1997, Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice., J Biol Chem, 272, 27307, 10.1074/jbc.272.43.27307 · DOI · Paper page
  111. Canan Koch, 1996, Identification of the first retinoid X receptor homodimer antagonist., J Med Chem, 39, 3229, 10.1021/jm960311d · DOI
  112. Lala, 1996, Activation of specific RXR heterodimers by an antagonist of RXR homodimers., Nature, 383, 450, 10.1038/383450a0 · DOI · Paper page
  113. Minucci, 1997, Retinoid × receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression., Mol Cell Biol, 17, 644, 10.1128/MCB.17.2.644 · DOI · Paper page
  114. Vivat, 1997, A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers., EMBO J, 16, 5697, 10.1093/emboj/16.18.5697 · DOI
  115. Werman, 1997, Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ)., J Biol Chem, 272, 20230, 10.1074/jbc.272.32.20230 · DOI · Paper page
  116. Adams, 1997, Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site., J Biol Chem, 272, 5128, 10.1074/jbc.272.8.5128 · DOI · Paper page
  117. Ristow, 1998, Obesity associated with a mutation in a genetic regulator of adipocyte differentiation., N Engl J Med, 339, 953, 10.1056/NEJM199810013391403 · DOI · Paper page
  118. Glass, 1997, Nuclear receptor coactivators., Curr Opin Cell Biol, 9, 222, 10.1016/S0955-0674(97)80066-X · DOI · Paper page
  119. Horwitz, 1996, Nuclear receptor coactivators and corepressors., Mol Endocrinol, 10, 1167
  120. Zamir, 1997, Stoichiometric and steric principles governing repression by nuclear hormone receptors., Genes Dev, 11, 835, 10.1101/gad.11.7.835 · DOI · Paper page
  121. Oñate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily., Science, 270, 1354, 10.1126/science.270.5240.1354 · DOI · Paper page
  122. Zhu, 1996, Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ., Gene Expr, 6, 185
  123. McInerney, 1998, Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation., Genes Dev, 12, 3357, 10.1101/gad.12.21.3357 · DOI · Paper page
  124. Zhou, 1998, Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer., Mol Endocrinol, 12, 1594, 10.1210/mend.12.10.0176 · doi:10.1210/mend.12.10.0176 · Paper page
  125. Westin, 1998, Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators., Nature, 395, 199, 10.1038/26040 · DOI · Paper page
  126. Qi, 1999, Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor α-regulated gene expression., Proc Natl Acad Sci USA, 96, 1585, 10.1073/pnas.96.4.1585 · DOI
  127. Dowell, 1997, p300 Functions as a coactivator for the peroxisome proliferator-activated receptor alpha., J Biol Chem, 272, 33435, 10.1074/jbc.272.52.33435 · DOI · Paper page
  128. Mizukami, 1997, The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR γ and CBP., Biochem Biophys Res Commun, 240, 61, 10.1006/bbrc.1997.7602 · DOI
  129. Schulman, 1998, Transactivation by retinoid × receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: intermolecular synergy requires only the PPARγ hormone-dependent activation function., Mol Cell Biol, 18, 3483, 10.1128/MCB.18.6.3483 · DOI · Paper page
  130. Kamei, 1996, A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors., Cell, 85, 403, 10.1016/S0092-8674(00)81118-6 · DOI · Paper page
  131. Hanstein, 1996, p300 Is a component of an estrogen receptor coactivator complex., Proc Natl Acad Sci USA, 93, 11540, 10.1073/pnas.93.21.11540 · DOI · Paper page
  132. Chakravarti, 1996, Role of CBP/P300 in nuclear receptor signalling., Nature, 383, 99, 10.1038/383099a0 · DOI · Paper page
  133. Arias, 1994, Activation of cAMP and mitogen responsive genes relies on a common nuclear factor., Nature, 370, 226, 10.1038/370226a0 · DOI · Paper page
  134. Eckner, 1996, Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation., Genes Dev, 10, 2478, 10.1101/gad.10.19.2478 · DOI · Paper page
  135. Bhattacharya, 1996, Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α., Nature, 383, 344, 10.1038/383344a0 · DOI · Paper page
  136. Zhang, 1996, Two contact regions between Stat1 and CBP/p300 in interferon γ signaling., Proc Natl Acad Sci USA, 93, 15092, 10.1073/pnas.93.26.15092 · DOI · Paper page
  137. Horvai, 1997, Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300., Proc Natl Acad Sci USA, 94, 1074, 10.1073/pnas.94.4.1074 · DOI · Paper page
  138. Perkins, 1997, Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator., Science, 275, 523, 10.1126/science.275.5299.523 · DOI · Paper page
  139. Giles, 1998, Conjunction dysfunction: CBP/p300 in human disease., Trends Genet, 14, 178, 10.1016/S0168-9525(98)01438-3 · DOI · Paper page
  140. Janknecht, 1996, Transcription – a growing coactivator network., Nature, 383, 22, 10.1038/383022a0 · DOI · Paper page
  141. Shikama, 1997, The p300/CBP family: integrating signals with transcription factors and chromatin., Trends Cell Biol, 7, 230, 10.1016/S0962-8924(97)01048-9 · DOI · Paper page
  142. Schulman, 1997, The phantom ligand effect: allosteric control of transcription by the retinoid X receptor., Genes Dev, 11, 299, 10.1101/gad.11.3.299 · DOI
  143. Mascrez, 1998, The RXRα ligand-dependent activation function (AF-2) is important for mouse development., Development, 125, 4691, 10.1242/dev.125.23.4691 · DOI
  144. Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis., Cell, 92, 829, 10.1016/S0092-8674(00)81410-5 · DOI · Paper page
  145. Zhu, 1997, Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor., J Biol Chem, 272, 25500, 10.1074/jbc.272.41.25500 · DOI · Paper page
  146. Yuan, 1998, The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion., Proc Natl Acad Sci USA, 95, 7939, 10.1073/pnas.95.14.7939 · DOI · Paper page
  147. Rachez, 1998, A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system., Genes Dev, 12, 1787, 10.1101/gad.12.12.1787 · DOI · Paper page
  148. Miyata, 1998, Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor α and liver-X-receptor α., Mol Cell Endocrinol, 146, 69, 10.1016/S0303-7207(98)00196-8 · DOI
  149. Treuter, 1998, A regulatory role for RIP140 in nuclear receptor activation., Mol Endocrinol, 12, 864, 10.1210/mend.12.6.0123 · DOI
  150. Krey, 1995, Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter., Mol Endocrinol, 9, 219
  151. Bannister, 1996, The CBP co-activator is a histone acetyltransferase., Nature, 384, 641, 10.1038/384641a0 · DOI · Paper page
  152. Ogryzko, 1996, The transcriptional coactivators p300 and CBP are histone acetyltransferases., Cell, 87, 953, 10.1016/S0092-8674(00)82001-2 · DOI · Paper page
  153. Cullingford, 1998, Distribution of mRNAs encoding the peroxisome proliferator-activated receptor α, β, and γ and the retinoid X receptor α, β, and γ in rat central nervous system., J Neurochem, 70, 1366, 10.1046/j.1471-4159.1998.70041366.x · DOI · Paper page
  154. Braissant, 1998, Differential expression of peroxisome proliferator-activated receptor-α, -β, and -γ during rat embryonic development., Endocrinology, 139, 2748, 10.1210/endo.139.6.6049 · doi:10.1210/endo.139.6.6049 · Paper page
  155. Lemberger, 1996, PPAR tissue distribution and interactions with other hormone-signaling pathways., Ann NY Acad Sci, 804, 231, 10.1111/j.1749-6632.1996.tb18619.x · DOI
  156. Palmer, 1998, Peroxisome proliferator activated receptor-α expression in human liver., Mol Pharmacol, 53, 14, 10.1124/mol.53.1.14 · DOI · Paper page
  157. Mukherjee, 1997, Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists., J Biol Chem, 272, 8071, 10.1074/jbc.272.12.8071 · DOI · Paper page
  158. Auboeuf, 1997, Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: no alteration in adipose tissue of obese and NIDDM patients., Diabetes, 48, 1319, 10.2337/diab.46.8.1319 · DOI · Paper page
  159. Steineger, 1994, Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells – hormonal modulation of fatty-acid-induced transcription., Eur J Biochem, 225, 967, 10.1111/j.1432-1033.1994.0967b.x · DOI
  160. Lemberger, 1994, Regulation of the peroxisome proliferator-activated receptor α gene by glucocorticoids., J Biol Chem, 269, 24527, 10.1016/S0021-9258(17)31420-5 · DOI · Paper page
  161. Lemberger, 1996, Expression of the peroxisome proliferator-activated receptor α gene is stimulated by stress and follows a diurnal rhythm., J Biol Chem, 271, 1764, 10.1074/jbc.271.3.1764 · DOI · Paper page
  162. Lemberger, 1996, Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology., Annu Rev Cell Dev Biol, 12, 335, 10.1146/annurev.cellbio.12.1.335 · DOI · Paper page
  163. Yamada, 1995, Suppressive effect of growth hormone on the expression of peroxisome proliferator-activated receptor in cultured rat hepatocytes., Res Commun Mol Pathol Pharmacol, 90, 173
  164. Wan, 1995, Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease., Life Sci, 56, 307, 10.1016/0024-3205(94)00953-8 · DOI
  165. Sterchele, 1996, Regulation of peroxisome proliferator-activated receptor α mRNA in rat liver., Arch Biochem Biophys, 326, 281, 10.1006/abbi.1996.0077 · doi:10.1006/abbi.1996.0077
  166. Zhou, 1998, Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells., Proc Natl Acad Sci USA, 95, 8898, 10.1073/pnas.95.15.8898 · DOI
  167. Dreyer, 1993, Positive regulation of the peroxisomal β-oxydation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)., Biol Cell, 77, 67, 10.1016/S0248-4900(05)80176-5 · DOI · Paper page
  168. Granneman, 1998, Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes., J Neurosci Res, 51, 563, 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D · DOI
  169. Lim, 1999, Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ., Genes Dev, 13, 1561, 10.1101/gad.13.12.1561 · DOI · Paper page
  170. Tontonoz, 1994, mPPARγ2: tissue-specific regulator of an adipocyte enhancer., Genes Dev, 8, 1224, 10.1101/gad.8.10.1224 · DOI · Paper page
  171. Mansen, 1996, Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa., Biochem Biophys Res Commun, 222, 844, 10.1006/bbrc.1996.0832 · DOI · Paper page
  172. Lefebvre, 1998, Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice., Nat Med, 4, 1053, 10.1038/2036 · DOI · Paper page
  173. Saez, 1998, Activators of the nuclear receptor PPARγ enhance colon polyp formation., Nat Med, 4, 1058, 10.1038/2042 · DOI · Paper page
  174. Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids., J Clin Invest, 99, 2416, 10.1172/JCI119424 · DOI · Paper page
  175. Xing, 1997, TNFα-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression., Endocrinology, 138, 2776, 10.1210/endo.138.7.5242 · DOI · Paper page
  176. Hill, 1997, Decreased expression of murine PPARγ in adipose tissue during endotoxemia., Endocrinology, 138, 3073, 10.1210/endo.138.7.5379 · DOI
  177. Rousseau, 1997, Developmental and nutritional changes of ob and PPARγ2 gene expression in rat white adipose tissue., Biochem J, 321, 451, 10.1042/bj3210451 · DOI
  178. Pearson, 1996, The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPARγ and aP2 in adipose tissue of high-fat-fed rats., Biochem Biophys Res Commun, 229, 752, 10.1006/bbrc.1996.1876 · doi:10.1006/bbrc.1996.1876
  179. Shimoike, 1998, Subcutaneous or visceral adipose tissue expression of the PPARgamma gene is not altered in the fatty (fa/fa) Zucker rat., Metabolism, 47, 1494, 10.1016/S0026-0495(98)90076-2 · DOI
  180. Vidal-Puig, 1996, Regulation of PPARγ gene expression by nutrition and obesity in rodents., J Clin Invest, 97, 2553, 10.1172/JCI118703 · DOI · Paper page
  181. Hotta, 1998, Relationships of PPARγ and PPARγ2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys., Int J Obes Relat Metab Disord, 22, 1000, 10.1038/sj.ijo.0800718 · DOI
  182. Rieusset, 1999, Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-γ in human adipocytes., Diabetes, 48, 699, 10.2337/diabetes.48.4.699 · DOI
  183. Kruszynska, 1998, Skeletal muscle peroxisome proliferator-activated receptor γ expression in obesity and non-insulin-dependent diabetes mellitus., J Clin Invest, 101, 543, 10.1172/JCI1076 · DOI
  184. Yen, 1997, Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPAR γ2 missense mutation., Biochem Biophys Res Commun, 241, 270, 10.1006/bbrc.1997.7798 · DOI · Paper page
  185. Deeb, 1998, A Pro12Ala substitution in PPARγ 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity., Nat Genet, 20, 284, 10.1038/3099 · DOI · Paper page
  186. Ringel, 1999, Pro12Ala missense mutation of the peroxisome proliferator-activated receptor γ and diabetes mellitus., Biochem Biophys Res Commun, 254, 450, 10.1006/bbrc.1998.9962 · DOI
  187. Mori, 1998, Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men., Biochem Biophys Res Commun, 251, 195, 10.1006/bbrc.1998.9421 · DOI
  188. Vigouroux, 1998, Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes., Diabetes, 47, 490, 10.2337/diabetes.47.3.490 · DOI
  189. Beamer, 1998, Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations., Diabetes, 47, 1806, 10.2337/diabetes.47.11.1806 · DOI · Paper page
  190. Hanis, 1996, A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2., Nat Genet, 13, 161, 10.1038/ng0696-161 · DOI · Paper page
  191. Norman, 1997, Genome wide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21–q22. Pima Diabetes Gene Group., Am J Hum Genet, 60, 166
  192. Suruga, 1999, Transcriptional regulation of cellular retinol-binding protein, type II gene expression in small intestine by dietary fat., Arch Biochem Biophys, 362, 159, 10.1006/abbi.1998.1018 · DOI
  193. Poirier, 1997, Fatty acid regulation of fatty acid-binding protein expression in the small intestine, Am J Physiol, 273, G289
  194. Mallordy, 1995, Evidence for transcriptional induction of the liver fatty-acid-binding-protein gene by bezafibrate in the small intestine., Eur J Biochem, 227, 801, 10.1111/j.1432-1033.1995.tb20204.x · doi:10.1111/j.1432-1033.1995.tb20204.x
  195. Bass, 1985, Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate., J Biol Chem, 260, 1432, 10.1016/S0021-9258(18)89610-7 · DOI · Paper page
  196. Poirier, 1996, Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP)., Eur J Biochem, 238, 368, 10.1111/j.1432-1033.1996.0368z.x · DOI · Paper page
  197. Rigotti, 1997, Scavenger receptor BI: a cell surface receptor for high density lipoprotein., Curr Opin Lipidol, 8, 181, 10.1097/00041433-199706000-00009 · DOI · Paper page
  198. Fruchart, 1998, Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group., Am J Cardiol, 81, 912
  199. Vu-Dac, 1998, The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates., J Biol Chem, 273, 25713, 10.1074/jbc.273.40.25713 · DOI · Paper page
  200. Widom, 1992, Repression by ARP-1 sensitizes apolipoprotein-AI gene responsiveness to RXRα and retinoic acid., Mol Cell Biol, 12, 3380, 10.1128/MCB.12.8.3380 · DOI

200 of 383 shown

Cited by

See all 3,086

Metadata

Authors
Desvergne, B., & Wahli, W.
Venue
Endocrine Reviews
Publisher
The Endocrine Society
Published
1999-10-01
Volume
20
Issue
5
Pages
649-688
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
DOI
10.1210/edrv.20.5.0380
OpenAlex
W2022048961
Cited by
3,086
References
25
FWCI
29.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*. https://app.cochat.ai/papers/10.1210/edrv.20.5.0380
The paper
Desvergne, B., & Wahli, W. (1999). Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*. Endocrine Reviews. https://doi.org/10.1210/edrv.20.5.0380

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.